Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): Two case reports

被引:13
作者
Staedt, J [1 ]
Stoppe, G [1 ]
Riemann, H [1 ]
Hajak, G [1 ]
Ruther, E [1 ]
Riederer, P [1 ]
机构
[1] UNIV WURZBURG,DEPT PSYCHIAT,D-8700 WURZBURG,GERMANY
关键词
nocturnal myoclonus syndrome; NMS; lamotrigine; dopamine; glutamate;
D O I
10.1007/BF01271247
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In previous investigations we found an increase of D2 dopamine receptors in the striatum of patients with nocturnal myoclonus syndrome (NMS) after treatment with dopamimetics. Under the hypothesis, that, according to animal experiments, the glutamatergic system could be involved in this atypical dopaminergic up-regulation in NMS. The glutamate release inhibitor lamotrigine was tested in up to now two NMS patients. The results and the success of this approach and its implications are discussed.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 20 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]   GLUTAMATE-DOPAMINE INTERACTIONS IN THE VENTRAL STRIATUM - ROLE IN LOCOMOTOR-ACTIVITY AND RESPONDING WITH CONDITIONED REINFORCEMENT [J].
BURNS, LH ;
EVERITT, BJ ;
KELLEY, AE ;
ROBBINS, TW .
PSYCHOPHARMACOLOGY, 1994, 115 (04) :516-528
[3]   PRIMATE MODELS OF MOVEMENT-DISORDERS OF BASAL GANGLIA ORIGIN [J].
DELONG, MR .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :281-285
[4]   PHASIC VERSUS TONIC DOPAMINE RELEASE AND THE MODULATION OF DOPAMINE SYSTEM RESPONSIVITY - A HYPOTHESIS FOR THE ETIOLOGY OF SCHIZOPHRENIA [J].
GRACE, AA .
NEUROSCIENCE, 1991, 41 (01) :1-24
[5]   GLUTAMATE-DOPAMINE INTERACTIONS IN THE BASAL GANGLIA - RELATIONSHIP TO PARKINSONS-DISEASE [J].
GREENAMYRE, JT .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 91 (2-3) :255-269
[6]   DOPAMINE RELEASE IN THE NUCLEUS-CAUDATUS AND IN THE NUCLEUS-ACCUMBENS IS UNDER GLUTAMATERGIC CONTROL THROUGH NON-NMDA RECEPTORS - A STUDY IN FREELY-MOVING RATS [J].
IMPERATO, A ;
HONORE, T ;
JENSEN, LH .
BRAIN RESEARCH, 1990, 530 (02) :223-228
[7]   PHARMACOLOGICAL STUDIES ON LAMOTRIGINE, A NOVEL POTENTIAL ANTIEPILEPTIC DRUG .2. NEUROCHEMICAL STUDIES ON THE MECHANISM OF ACTION [J].
LEACH, MJ ;
MARDEN, CM ;
MILLER, AA .
EPILEPSIA, 1986, 27 (05) :490-497
[8]  
MAURA G, 1988, J PHARMACOL EXP THER, V247, P680
[9]   DOPAMINE DECREASES CELL EXCITABILITY IN RAT STRIATAL NEURONS BY PRESYNAPTIC AND POSTSYNAPTIC MECHANISMS [J].
MERCURI, N ;
BERNARDI, G ;
CALABRESI, P ;
COTUGNO, A ;
LEVI, G ;
STANZIONE, P .
BRAIN RESEARCH, 1985, 358 (1-2) :110-121
[10]   MODULATION OF STRIATAL [GLUTAMIC-H-3 ACID RELEASE BY DOPAMINERGIC DRUGS [J].
MITCHELL, PR ;
DOGGETT, NS .
LIFE SCIENCES, 1980, 26 (24) :2073-2081